A propensity score for receiving carbapenem adjusted, multivariable analysis of 30-day relapse bacteraemia for 101 patients with ESBL-producing E. coli and K. pneumoniae bacteraemia, receiving either empiric piperacllin-tazobactam or carbapenem.

A propensity score for receiving carbapenem adjusted, multivariable analysis of 30-day relapse bacteraemia for 101 patients with ESBL-producing E. coli and K. pneumoniae bacteraemia, receiving either empiric piperacllin-tazobactam or carbapenem.